GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
111 hedge funds and large institutions have $67.2M invested in Sanofi Contingent Value Rights in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 22
Holders
111
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$603K | |
| 2 | +$556K | |
| 3 | +$56.7K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$44.9K |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$28.4K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$113K | |
| 3 | -$93.8K | |
| 4 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$81K |
| 5 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
-$68K |